tirzepatide nejm ๐ข New in NEJM: ๐ vs. Semaglutide ๐ for obesity (no diabetes) ๐งช 72-week RCT highlights: โ๏ธ Weight loss: โ20.2% vs. โ13.7% ๐ Waist โ: 18.4 cm vs. 13.0 cm ๐ฏ More patients hit โฅ25% lossโฆ In patients with type 2
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Oct 8 - Oct 13


























